What is Interphase?
Interphase operates as a premier consultancy firm dedicated to the intersection of medical and commercial strategy. The company provides mission-critical advisory services tailored specifically for the pharmaceutical, biotechnology, and medical device sectors. By bridging the gap between complex clinical requirements and commercial viability, Interphase serves as a vital partner for enterprises navigating the rigorous regulatory and market landscapes of modern healthcare. Their market position is defined by a deep technical expertise that enables clients to optimize product lifecycles and maximize therapeutic impact.
How much funding has Interphase raised?
Interphase has raised a total of $1.2M across 2 funding rounds:
Debt
$350K
Debt
$888K
Debt (2020): $350K with participation from PPP
Debt (2021): $888K led by PPP
Key Investors in Interphase
PPP
Public-Private Partnership
What's next for Interphase?
With the recent influx of capital, Interphase is poised to scale its operational footprint and enhance its proprietary consulting frameworks. The firm is expected to prioritize the expansion of its advisory team, focusing on senior-level talent capable of managing large-scale enterprise engagements. Furthermore, the strategic allocation of these funds will likely support the development of advanced analytical tools designed to provide deeper insights into market access and commercialization strategies. As the life sciences sector continues to evolve, Interphase remains committed to maintaining its competitive edge through data-driven decision-making and strategic foresight.
See full Interphase company page